tiprankstipranks
Nautilus Biotechnolgy, Inc. (NAUT)
:NAUT
US Market

Nautilus Biotechnolgy (NAUT) Income Statement

Compare
128 Followers

Nautilus Biotechnolgy Income Statement

Last quarter (Q4 2024), Nautilus Biotechnolgy's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Nautilus Biotechnolgy's net income was $-17.59M. See Nautilus Biotechnolgy’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -5.71M$ -3.42M$ -2.84M$ -2.35M
Operating Expenses
$ 81.48M$ 76.15M$ 63.62M$ 50.50M$ 15.74M
Depreciation and Amortization
$ 0.00$ 1.85M$ 3.42M$ 2.84M$ 2.35M
EBITDA
$ 0.00$ -74.30M$ -54.51M$ -47.47M$ -13.27M
Operating Income
$ 0.00$ -76.15M$ -63.62M$ -50.50M$ -15.74M
Other Income/Expenses
$ 0.00$ 12.48M$ 5.69M$ 183.00K$ 125.00K
Pretax Income
$ -70.78M$ -63.67M$ -57.92M$ -50.31M$ -15.62M
Net Income
$ -70.78M$ -63.67M$ -63.74M$ -50.31M$ -15.62M
Per Share Metrics
Basic EPS
$ -0.56$ -0.51$ -0.51$ -0.60$ -0.52
Diluted EPS
$ -0.56$ -0.51$ -0.51$ -0.60$ -0.52
Weighted Average Shares Outstanding
125.43M 124.92M 124.59M 84.46M 29.96M
Weighted Average Shares Outstanding (Diluted)
125.43M 124.92M 124.59M 84.46M 29.96M
Currency in USD

Nautilus Biotechnolgy Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis